Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization

Am Heart J. 2011 May;161(5):944-9. doi: 10.1016/j.ahj.2011.02.005.

Abstract

Background: Worsening renal function (WRF) commonly complicates the treatment of acute decompensated heart failure. Despite considerable investigation in this area, it remains unclear to what degree WRF is a reflection of treatment- versus patient-related factors. We hypothesized that if WRF is significantly influenced by factors intrinsic to the patient, then WRF during an index hospitalization should predict WRF during subsequent hospitalization.

Methods: Consecutive admissions to the Hospital of the University of Pennsylvania with a discharge diagnosis of congestive heart failure were reviewed. Patients with >1 hospitalization were retained for analysis.

Results: In total, 181 hospitalization pairs met the inclusion criteria. Baseline patient characteristics demonstrated significant correlation between hospitalizations (P ≤ .002 for all) but minimal association with WRF. In contrast, variables related to the aggressiveness of diuresis were weakly correlated between hospitalizations but significantly associated with WRF (P ≤ .024 for all). Consistent with the primary hypothesis, WRF during the index hospitalization was strongly associated with WRF during subsequent hospitalization (odds ratio [OR] 2.7, P = .003). This association was minimally altered after controlling for traditional baseline characteristics (OR 2.5, P = .006) and in-hospital treatment-related parameters (OR 2.8, P = .005).

Conclusions: A prior history of WRF is strongly associated with subsequent episodes of WRF, independent of in-hospital treatment received. These results suggest that baseline factors intrinsic to the patient's cardiorenal pathophysiology have substantial influence on the subsequent development of WRF.

Publication types

  • Comparative Study

MeSH terms

  • Cardiovascular Agents / adverse effects*
  • Cardiovascular Agents / therapeutic use
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate / drug effects*
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Hospitalization*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pennsylvania / epidemiology
  • Prognosis
  • Renal Insufficiency / chemically induced*
  • Renal Insufficiency / epidemiology
  • Renal Insufficiency / physiopathology
  • Retrospective Studies
  • Risk Factors
  • Survival Rate / trends

Substances

  • Cardiovascular Agents